RAPT Therapeutics files corporate presentation; no specific material news disclosed

RAPT Therapeutics, Inc.

Filed under Item 7.01 as a Regulation FD disclosure; no new financial or clinical data provided.
Presentation title slide: 'THE SCIENCE TO OVERCOME INFLAMMATION'; content not detailed in excerpt.
No pipeline updates, guidance changes, or business developments were furnished.
Presentation is furnished, not filed, and not incorporated by reference into SEC filings.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.